🗂️ Navigation

Insilico Medicine

AI-powered drug discovery and development.

Visit Website →

Overview

Insilico Medicine is a clinical-stage biotech company that has developed Pharma.AI, a comprehensive AI platform for drug discovery. The platform integrates deep learning and generative AI to identify novel drug targets, design new molecules, and predict the outcomes of clinical trials. They have a pipeline of therapeutic programs in areas such as fibrosis, oncology, and immunology.

✨ Key Features

  • PandaOmics™ for target discovery
  • Chemistry42™ for generative chemistry and de novo drug design
  • InClinico™ for clinical trial outcome prediction
  • End-to-end drug discovery suite
  • Robotic labs for automated experiments

🎯 Key Differentiators

  • End-to-end platform covering biology, chemistry, and clinical development.
  • Use of generative AI for novel molecule design.
  • Proven success in bringing an AI-discovered drug to clinical trials.

Unique Value: Offers a complete, end-to-end AI solution to accelerate all stages of preclinical drug discovery.

🎯 Use Cases (4)

Target identification and validation Small molecule design Biomarker development Predicting clinical trial success

✅ Best For

  • Advanced a drug candidate for Idiopathic Pulmonary Fibrosis, discovered and designed with their AI platform, to Phase II clinical trials.

💡 Check With Vendor

Verify these considerations match your specific requirements:

  • NA

🏆 Alternatives

Atomwise Recursion Pharmaceuticals Schrödinger

Provides a more integrated and comprehensive platform than point solutions that only address one part of the drug discovery process.

💻 Platforms

Web API

🔌 Integrations

API

🛟 Support Options

  • ✓ Email Support
  • ✓ Dedicated Support (Enterprise tier)

💰 Pricing

Contact for pricing

Free tier: NA

Visit Insilico Medicine Website →